Grants paid by Aim at Melanoma
EIN 56-2427805 · Sacramento, CA · Form 990, Schedule I · NTEE G30
Aim at Melanoma of Sacramento, CA (EIN 56-2427805) reported 22 grants paid totaling $2,271,750 to 4 recipients in tax years 2018–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$2,271,750
22 grants
Recipients
4
distinct organizations
Tax years
2018–2024
8 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 4 | $323,850 | — |
| 2019 | 4 | $175,000 | — |
| 2020 | 3 | $73,300 | — |
| 2021 | 3 | $228,200 | — |
| 2022 | 6 | $496,000 | — |
| 2023 | 1 | $500,400 | — |
| 2024 | 1 | $475,000 | — |
Top recipients
The 4 recipients receiving the most from Aim at Melanoma, by grants paid, out of 4 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Mtbc Melanoma Tissue Bank Consortium 46-2454076 | A | Sacramento, CA | 8 | $1,956,250 | 2024 |
| Upmc Univ of Pittsburgh Cancer Institute 25-0965591 | A | Pittsburgh, PA | 6 | $195,000 | 2022 |
| Ohsu Knight Cancer Institute 23-7083114 | A | Portland, OR | 6 | $80,500 | 2022 |
| Md Anderson Cancer Center 74-6000203 | A | Houston, TX | 2 | $40,000 | 2019 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 22 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Mtbc Melanoma Tissue Bank Consortium Sacramento, CA | A | $475,000 | paid | TISSUE BANK | 202521989349301552 |
| 2023 | Mtbc Melanoma Tissue Bank Consortium Sacramento, CA | A | $500,400 | paid | TISSUE BANK | 202442019349301109 |
| 2022 | Mtbc Melanoma Tissue Bank Consortium Sacramento, CA | A | $200,000 | paid | TISSUE BANK | 202400409349300915 |
| 2022 | Mtbc Melanoma Tissue Bank Consortium Sacramento, CA | A | $200,000 | paid | TISSUE BANK | 202301779349300420 |
| 2022 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $38,000 | paid | CANCER AND MELANOMA RESEARCH | 202301779349300420 |
| 2022 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $38,000 | paid | CANCER AND MELANOMA RESEARCH | 202400409349300915 |
| 2022 | Ohsu Knight Cancer Institute Portland, OR | A | $10,000 | paid | CANCER AND MELANOMA RESEARCH | 202400409349300915 |
| 2022 | Ohsu Knight Cancer Institute Portland, OR | A | $10,000 | paid | CANCER AND MELANOMA RESEARCH | 202301779349300420 |
| 2021 | Mtbc Melanoma Tissue Bank Consortium San Rafael, CA | A | $200,000 | paid | TISSUE BANK | 202241929349300009 |
| 2021 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $20,000 | paid | CANCER AND MELANOMA RESEARCH | 202241929349300009 |
| 2021 | Ohsu Knight Cancer Institute Portland, OR | A | $8,200 | paid | CANCER AND MELANOMA RESEARCH | 202241929349300009 |
| 2020 | Mtbc Melanoma Tissue Bank Consortium San Rafael, CA | A | $50,000 | paid | TISSUE BANK | 202101829349300020 |
| 2020 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $15,000 | paid | CANCER AND MELANOMA RESEARCH | 202101829349300020 |
| 2020 | Ohsu Knight Cancer Institute Portland, OR | A | $8,300 | paid | CANCER AND MELANOMA RESEARCH | 202101829349300020 |
| 2019 | Mtbc Melanoma Tissue Bank Consortium San Rafael, CA | A | $120,000 | paid | TISSUE BANK | 202032379349300528 |
| 2019 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $30,000 | paid | CANCER AND MELANOMA RESEARCH | 202032379349300528 |
| 2019 | Md Anderson Cancer Center Houston, TX | A | $15,000 | paid | CANCER AND MELANOMA RESEARCH | 202032379349300528 |
| 2019 | Ohsu Knight Cancer Institute Portland, OR | A | $10,000 | paid | CANCER AND MELANOMA RESEARCH | 202032379349300528 |
| 2018 | Mtbc Melanoma Tissue Bank Consortium San Rafael, CA | A | $210,850 | paid | TISSUE BANK | 201932189349301108 |
| 2018 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $54,000 | paid | CANCER AND MELANOMA RESEARCH | 201932189349301108 |
| 2018 | Ohsu Knight Cancer Institute Portland, OR | A | $34,000 | paid | CANCER AND MELANOMA RESEARCH | 201932189349301108 |
| 2018 | Md Anderson Cancer Center Houston, TX | A | $25,000 | paid | CANCER AND MELANOMA RESEARCH | 201932189349301108 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202521989349301552 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202442019349301109 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202301779349300420 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202400409349300915 |
| 990 | 2021 | 2021-12-31 | not stated | 2021v4.2 | 202241929349300009 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202101829349300020 |
| 990 | 2019 | 2019-12-31 | not stated | 2019v5.1 | 202032379349300528 |
| 990 | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201932189349301108 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/562427805.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.